Dr. Seetharam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5777 E. Mayo Boulevard
Phoenix, AZ 85050
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2004 - 2007
Mysore Medical CollegeClass of 1998
Certifications & Licensure
CA State Medical License 2006 - Present
AZ State Medical License 2010 - 2026
NY State Medical License 2006 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas Start of enrollment: 2023 Aug 31
Roles: Contact
Publications & Presentations
PubMed
- Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting.Ronen Stoff, Svetomir N Markovic, Robert R McWilliams, Lisa A Kottschade, Heather N Montane
Melanoma Research. 2024-12-01 - Cardiac Tumors: Review.Carlos J T Karigyo, Beatriz Mella S Pessoa, Samuel Pissinati Nicacio, Emma Terwilliger, Philippos Costa
Brazilian Journal of Cardiovascular Surgery. 2024-07-22 - Case report: Metastatic refractory undifferentiated small round-cell sarcoma successfully treated with surufatinib and camrelizumab.Yong Li, Jinpeng Huang, Xian Chen, Yongsong Ye, Xiaohua Du
Frontiers in Oncology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
